Resurgence of Polymyxin B for MDRXDR Gram-Negative Infections: An Overview of Current Evidence
Joint Authors
Garg, Suneel Kumar
Singh, Omender
Juneja, Deven
Tyagi, Niraj
Khurana, Amandeep Singh
Qamra, Amit
Motlekar, Salman
Barkate, Hanmant
Source
Critical Care Research and Practice
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-07-06
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Polymyxin B has resurged in recent years as a last resort therapy for Gram-negative multidrug-resistant (MDR) and extremely drug resistant (XDR) infections.
Understanding newer evidence on polymyxin B is necessary to guide clinical decision making.
Here, we present a literature review of polymyxin B in Gram-negative infections with update on its pharmacology.
American Psychological Association (APA)
Garg, Suneel Kumar& Singh, Omender& Juneja, Deven& Tyagi, Niraj& Khurana, Amandeep Singh& Qamra, Amit…[et al.]. 2017. Resurgence of Polymyxin B for MDRXDR Gram-Negative Infections: An Overview of Current Evidence. Critical Care Research and Practice،Vol. 2017, no. 2017, pp.1-10.
https://search.emarefa.net/detail/BIM-1139809
Modern Language Association (MLA)
Garg, Suneel Kumar…[et al.]. Resurgence of Polymyxin B for MDRXDR Gram-Negative Infections: An Overview of Current Evidence. Critical Care Research and Practice No. 2017 (2017), pp.1-10.
https://search.emarefa.net/detail/BIM-1139809
American Medical Association (AMA)
Garg, Suneel Kumar& Singh, Omender& Juneja, Deven& Tyagi, Niraj& Khurana, Amandeep Singh& Qamra, Amit…[et al.]. Resurgence of Polymyxin B for MDRXDR Gram-Negative Infections: An Overview of Current Evidence. Critical Care Research and Practice. 2017. Vol. 2017, no. 2017, pp.1-10.
https://search.emarefa.net/detail/BIM-1139809
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1139809
